Vita Life Sciences Limited (VLS.AX)
AUD 1.78
(0.0%)
AUD 1.78
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 12.98 Million | 7.68 Million | 5.88 Million | 7.54 Million | 2.02 Million | 2.84 Million |
| Net Income | 9.08 Million | 7.08 Million | 8.29 Million | 6.09 Million | 3.13 Million | 2.43 Million |
| Depreciation & Amortization | 512 Thousand | 599 Thousand | 409 Thousand | 553 Thousand | 604 Thousand | 403 Thousand |
| Deferred income taxes | 1.29 Million | -712.59 Thousand | -373 Thousand | 68 Thousand | -434 Thousand | -922 Thousand |
| Stock-based compensation | 683.9 Thousand | 712.59 Thousand | 207.97 Thousand | 91.69 Thousand | 51.64 Thousand | 35.87 Thousand |
| Change in working capital | 2.38 Million | -6.29 Million | -2.61 Million | 945 Thousand | -1 Million | 506 Thousand |
| Other non-cash items | -973 Thousand | 6.29 Million | 3.71 Million | -60 Thousand | 1.77 Million | -2.84 Million |
| Investing Cash Flow | -660 Thousand | -139 Thousand | -155 Thousand | -89 Thousand | -579 Thousand | -372 Thousand |
| Investments in PPE | -660 Thousand | -139 Thousand | -155 Thousand | -89 Thousand | -579 Thousand | -372 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -2.87 Million | -3.1 Million | -4.38 Million | -3.03 Million | -2.73 Million | -3.1 Million |
| Debt repayment | -171 Thousand | -338 Thousand | -1.53 Million | -402 Thousand | -577 Thousand | -329 Thousand |
| Dividends payments | -3.36 Million | -3.03 Million | -2.89 Million | -1.97 Million | -2.01 Million | -2.01 Million |
| Common Stock Repurchased | -208 Thousand | -311 Thousand | - | -656 Thousand | -145 Thousand | -757 Thousand |
| Common Stock Issuance | 871 Thousand | 582 Thousand | 40 Thousand | - | - | - |
| Other Financing Activities | -171 Thousand | 582 Thousand | 40 Thousand | - | 523 Thousand | - |
| Accounts receivables | -2.23 Million | -1.86 Million | -175 Thousand | 793 Thousand | -662 Thousand | -412 Thousand |
| Accounts payables | 985 Thousand | 844 Thousand | 1.63 Million | 546 Thousand | 524 Thousand | 731 Thousand |
| Inventory | 4.25 Million | -4.09 Million | -4.18 Million | -289 Thousand | -707 Thousand | -956 Thousand |
| Other working capital | -621 Thousand | -1.17 Million | 108 Thousand | -105 Thousand | -157.99 Thousand | 1.14 Million |
| Cash at beginning of period | 15.68 Million | 15.89 Million | 14.47 Million | 10.47 Million | 10.94 Million | 9.96 Million |
| Cash at end of period | 24.63 Million | 15.68 Million | 15.89 Million | 14.47 Million | 10.47 Million | 10.94 Million |
| Capital Expenditure | -660 Thousand | -139 Thousand | -155 Thousand | -89 Thousand | -579 Thousand | -372 Thousand |
| Effect of forex changes on cash | -505 Thousand | 264 Thousand | 71 Thousand | -425 Thousand | 284 Thousand | 199 Thousand |
| Net cash flow / Change in cash | 8.94 Million | -205 Thousand | 1.41 Million | 3.99 Million | -463 Thousand | 976 Thousand |
| Free Cash Flow | 12.32 Million | 7.54 Million | 5.73 Million | 7.45 Million | 1.44 Million | 2.47 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.29 Million | 5.09 Million | 9.08 Million | 3.98 Million | 7.08 Million | 3.43 Million |
| Depreciation & Amortization | 252 Thousand | 246 Thousand | 512 Thousand | 266 Thousand | 599 Thousand | 389 Thousand |
| Deferred income taxes | - | -2.95 Million | 1.29 Million | - | -712.59 Thousand | 4.71 Million |
| Stock-based compensation | 285.35 Thousand | 285.38 Thousand | 683.9 Thousand | 398.51 Thousand | 712.59 Thousand | 385.26 Thousand |
| Change in working capital | - | 2.18 Million | 2.38 Million | - | -6.29 Million | -5.88 Million |
| Other non-cash items | -1.92 Million | 3.56 Million | -973 Thousand | 846 Thousand | 6.29 Million | -243 Thousand |
| Investing Cash Flow | -8000.00 | -575 Thousand | -660 Thousand | -85 Thousand | -139 Thousand | -122 Thousand |
| Investments in PPE | -8000.00 | -575 Thousand | -660 Thousand | -85 Thousand | -139 Thousand | -122 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 433 Thousand | -1.82 Million | -2.87 Million | -1.04 Million | -3.1 Million | -1.91 Million |
| Debt repayment | -3.69 Million | -35 Thousand | -171 Thousand | -136 Thousand | -338 Thousand | -146 Thousand |
| Dividends payments | -3.26 Million | -1.61 Million | -3.36 Million | -1.74 Million | -3.03 Million | -1.45 Million |
| Common Stock Repurchased | -2000.00 | -176 Thousand | -208 Thousand | -32 Thousand | -311 Thousand | -311 Thousand |
| Common Stock Issuance | 3.85 Million | - | 871 Thousand | 871 Thousand | 582 Thousand | - |
| Other Financing Activities | - | -35 Thousand | -171 Thousand | - | 582 Thousand | -146 Thousand |
| Accounts receivables | - | -2.23 Million | -2.23 Million | - | -1.86 Million | -1.86 Million |
| Accounts payables | - | - | 985 Thousand | - | 844 Thousand | - |
| Inventory | - | 4.25 Million | 4.25 Million | - | -4.09 Million | -4.09 Million |
| Other working capital | - | 163 Thousand | -621 Thousand | - | -1.17 Million | 78 Thousand |
| Cash at beginning of period | 24.63 Million | 18.75 Million | 15.68 Million | 15.68 Million | 15.89 Million | 14.66 Million |
| Cash at end of period | 27.74 Million | 24.63 Million | 24.63 Million | 18.75 Million | 15.68 Million | 15.68 Million |
| Capital Expenditure | -8000.00 | -575 Thousand | -660 Thousand | -85 Thousand | -139 Thousand | -122 Thousand |
| Effect of forex changes on cash | 36 Thousand | -134 Thousand | -505 Thousand | -371 Thousand | 264 Thousand | 253 Thousand |
| Net cash flow / Change in cash | 3.11 Million | 5.88 Million | 8.94 Million | 3.06 Million | -205 Thousand | 1.02 Million |
| Free Cash Flow | 2.64 Million | 7.84 Million | 12.32 Million | 4.47 Million | 7.54 Million | 2.68 Million |
BGO
CWBR
LSEAW
6247
FAXXF
000063